Filing Details
- Accession Number:
- 0001179110-20-001419
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-10 19:24:03
- Reporting Period:
- 2020-02-06
- Accepted Time:
- 2020-02-10 19:24:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
896264 | Usana Health Sciences Inc | USNA | Medicinal Chemicals & Botanical Products (2833) | 870500306 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1537768 | A. Daniel Macuga | 3838 West Parkway Blvd. Salt Lake City UT 84120 | Chief Communications Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-02-06 | 873 | $0.00 | 4,969 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-02-06 | 370 | $80.71 | 4,599 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2020-02-06 | 3,470 | $70.75 | 8,069 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-02-06 | 3,470 | $80.00 | 4,599 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Units | Disposition | 2020-02-06 | 873 | $0.00 | 873 | $0.00 |
Common Stock | Stock - Settles Stock Appreciation Right | Disposition | 2020-02-06 | 30,000 | $0.00 | 30,000 | $70.75 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
17,784 | No | 4 | M | Direct | ||
0 | 2019-09-01 | 2020-03-01 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
- On May 1st, 2017, the reporting person was granted restricted stock units, vesting at 25% on each 6th of February thereafter.
- The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II.